Artelo Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2024 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q3 2024 | 2 | -$0.79 | -$0.79 | -$0.79 |
| Q4 2024 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q1 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
Artelo Biosciences, Inc. Earnings Date And Information
Artelo Biosciences, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.75 earnings per share for the quarter, topping analysts' consensus estimates of $-0.83 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Artelo Biosciences, Inc. has generated $-3 earnings per share over the last year ($-3.49 diluted earnings per share) and currently has a price-to-earnings ratio of -0.8. Artelo Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Artelo Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2023 | Q3 2023 | -$0.70 | -$0.83 | -0.13 | $0 | $0 |
| 08/10/2023 | Q2 2023 | -$0.81 | -$0.56 | 0.25 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.93 | -$0.72 | 0.21 | $0 | |
| 03/31/2023 | Q4 2022 | -$1.13 | $0 | |||
| 11/08/2022 | Q3 2022 | -$0.91 | -$0.79 | 0.12 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.85 | -$0.86 | -0.01 | $0 | |
| 05/12/2022 | Q1 2022 | -$1.27 | -$0.70 | 0.57 | $0 | |
| 01/12/2022 | Q4 2021 | -$0.90 | -$1.26 | -0.36 | $0 | |
| 11/29/2021 | Q3 2021 | -$1.50 | -$0.06 | 1.44 | $0 | |
| 07/12/2021 | Q2 2021 | -$0.09 | -$1.46 | -1.37 | $0 | |
| 04/13/2021 | Q1 2021 | -$0.11 | -$1.65 | -1.54 | $0 | |
| 01/14/2021 | Q4 2020 | -$0.10 | -$2.11 | -2.01 | $0 | |
| 11/04/2020 | Q3 2020 | -$0.36 | -$0.10 | 0.26 | $0 | |
| 07/13/2020 | Q2 2020 | -$0.40 | -$4.12 | -3.72 | $0 | |
| 04/13/2020 | Q1 2020 | -$6.00 | $0 | |||
| 01/14/2020 | Q4 2019 | -$5.83 | $0 | |||
| 11/25/2019 | Q3 2019 | -$0.51 | -$0.25 | 0.26 | $0 | |
| 07/15/2019 | Q2 2019 | -$0.42 | -$2.51 | -2.09 | $0 | |
| 04/15/2019 | Q1 2019 | -$3.32 | $0 | |||
| 01/14/2019 | Q4 2018 | -$4.76 | $0 |
Artelo Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Artelo Biosciences, Inc.'s earnings date?
Artelo Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did Artelo Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Artelo Biosciences, Inc. (:ARTL) reported $-0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.83 by $0.08.
-
How can I listen to Artelo Biosciences, Inc.'s earnings conference call?
The conference call for Artelo Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Artelo Biosciences, Inc.'s conference call transcript?
The conference call transcript for Artelo Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Artelo Biosciences, Inc. generate each year?
Artelo Biosciences, Inc. (:ARTL) has a recorded net income of $0. Artelo Biosciences, Inc. has generated $-3.49 earnings per share over the last four quarters.
-
What is Artelo Biosciences, Inc.'s price-to-earnings ratio?
Artelo Biosciences, Inc. (:ARTL) has a price-to-earnings ratio of -0.8 and price/earnings-to-growth ratio is 0.64.
